Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is used to support cognitive function and is prescribed for conditions such as cognitive impairment, dementia, vertigo, myoclonus and dyslexia in adult patients.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nootropil (piracetam) acts as a cognitive enhancer within the racetam class, targeting disorders of memory, balance and motor control. - Cognitive impairment: improves attention and short‑term memory performance. - Dementia: may modestly enhance cognitive function and daily living activities. - Vertigo: helps stabilize vestibular function and reduce dizziness episodes. - Myoclonus: reduces involuntary muscle jerks and improves motor coordination. - Dyslexia: supports reading accuracy and processing speed in affected individuals.

Adverse reactions to piracetam are generally mild, but monitoring is advised.

Common Side Effects: - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: occasional gastrointestinal upset. - Dizziness: transient light‑headedness. - Anxiety: increased nervousness or restlessness. - Fatigue: feeling of reduced energy.

Serious or Rare Side Effects: - Skin rash: possible allergic reaction. - Thrombocytopenia: reduced platelet count. - Depression: emergence of mood changes. - Seizures: rare occurrence, especially in predisposed individuals.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with impaired kidney function. - Behavioral monitoring: watch for mood or anxiety changes. - Hypersensitivity: discontinue if allergic reactions develop. - Elderly caution: start with lower doses due to increased sensitivity. - Pregnancy and lactation: safety unknown; avoid unless clearly needed. - Store at room temperature: keep in the original pack, protect from moisture.

Piracetam has a low interaction profile, yet certain combinations require attention.

Major Interactions (Avoid): - Concurrent use with other AMPA‑modulating agents: may cause overstimulation of neuronal activity. - Antiepileptic drugs: possible reduction in seizure‑control efficacy.

Moderate Interactions (Monitor Closely): - Alcohol: may intensify central nervous system side effects. - Caffeine: can increase insomnia risk. - Diuretics: may alter plasma concentrations of piracetam. - Anticoagulants: potential for increased bleeding tendency.